Raising awareness of new solutions in patient care
Inherent Biosciences Raises Seed Round, adds Board Members and Clinical Advisors
Inherent Biosciences today announced its initial capital raise led by Morning Star Foundation with additional participation from MedMountain Ventures, Kickstart Funds, Park City Angels, Rhythm VC and several angel investors. With the initial funding, Inherent will launch a male infertility diagnostic to guide infertility treatment.
Inherent Biosciences Wins $256K NSF Grant to predict COVID-19 infection severity and treatment response
The variation in symptoms and outcomes for COVID-19 progression make it challenging for healthcare workers to triage patients accurately. The development of a DNA methylation-based test to predict the severity of COVID-19 infection has tremendous potential for managing current and future pandemics.